Single-molecule studies reveal branched pathways for activator-dependent assembly of RNA polymerase II pre-initiation complexes

1. Download : Download high-res image (149KB)
2. Download : Download full-size image

     

DNA repair mechanisms in dividing and non-dividing cells

DNA damage created by endogenous or exogenous genotoxic agents can exist in multiple forms, and if allowed to persist, can promote genome instability and directly lead to various human diseases, particularly cancer, neurological abnormalities, immunodeficiency and premature aging. To avoid such deleterious outcomes, cells have evolved an array of DNA repair pathways, which carry out what is typically a multiple-step process to resolve specific DNA lesions and maintain genome integrity. To fully appreciate the biological contributions of the different DNA repair systems, one must keep in mind the cellular context within which they operate. For example, the human body is composed of non-dividing and dividing cell types, including, in the brain, neurons and glial cells. We describe herein the molecular mechanisms of the different DNA repair pathways, and review their roles in non-dividing and dividing cells, with an eye toward how these pathways may regulate the development of neurological disease.     

人XPB基因在核苷酸剪切修复和基因转录中的分子机制

核苷酸剪切修复(NER)途径是维持生物体基因组稳定的重要机制。人着色性干皮病B组(xeroderma pigmentosum group B,XPB)基因又名ERCC3基因,它既是NER途径不可缺少的成员又是转录因子TFIIH的最大p89亚基。它是具有从3’端→5’端依赖ATP的单链DNA解旋酶活性的蛋白质,执行依赖DNA的ATP酶和解旋酶功能,在损伤DNA修复和基因转录中均起重要作用,并将两者有机偶联。该基因突变将导致3种不同的遗传疾病：着色性干皮病(xeroderma pigmentosum,XP),科凯恩氏综合征(cockayne’s syndrome,CS),毛发硫营养不艮(trichothiodystrophy,TTD)。其基因型通过在DNA修复和转录中的功能与表型联系起来。另外,XPB与p53存在物理和功能上的相互作用。现从XPB的3个方面即“一个基因,两种功能,3种疾病”作一综述。     

Anti‐hsa‐miR‐59 alleviates premature senescence associated with Hutchinson‐Gilford progeria syndrome in mice

Hutchinson‐Gilford progeria syndrome (HGPS) is a lethal premature aging disorder without an effective therapeutic regimen. Because of their targetability and influence on gene expression, microRNAs (miRNAs) are attractive therapeutic tools to treat diseases. Here we identified that hsa‐miR‐59 (miR‐59) was markedly upregulated in HGPS patient cells and in multiple tissues of an HGPS mouse model (Lmna ^G609G/G609G ), which disturbed the interaction between RNAPII and TFIIH, resulting in abnormal expression of cell cycle genes by targeting high‐mobility group A family HMGA1 and HMGA2. Functional inhibition of miR‐59 alleviated the cellular senescence phenotype of HGPS cells. Treatment with AAV9‐mediated anti‐miR‐59 reduced fibrosis in the quadriceps muscle, heart, and aorta, suppressed epidermal thinning and dermal fat loss, and yielded a 25.5% increase in longevity of Lmna ^G609G/G609G mice. These results identify a new strategy for the treatment of HGPS and provide insight into the etiology of HGPS disease.